Swiss All Share Index
15.848,14
PKT
+74,77
PKT
+0,47
%
Werbung
Analysen zu Swiss All Share Index-Werten
Datum | Rating | Analyst | |
---|---|---|---|
20.01.05 | Novartis Hold | SEB | |
21.01.05 | Logitech Accumulate | Helvea | |
20.01.05 | Novartis Neutral | Sarasin Research | |
21.01.05 | Lindt Neutral | Sarasin Research | |
21.01.05 | Novartis Buy | Helvea | |
20.01.05 | Lindt Underperform | Goldman Sachs | |
19.01.05 | Novartis Equal-weight | Morgan Stanley | |
19.01.05 | Straumann Accumulate | Helvea | |
19.01.05 | Barry Callebaut Neutral | Helvea | |
19.01.05 | Zurich Insurance Overweight | Lehman Brothers | |
21.01.05 | Novartis Kaufen | Helaba Trust | |
19.01.05 | BB Biotech Kaufen | Hamburger Sparkasse | |
19.01.05 | Tecan (N) Reduce | Helvea | |
19.01.05 | Holcim In-Line | Goldman Sachs | |
20.01.05 | Logitech In-Line | Goldman Sachs | |
21.01.05 | Clariant Kaufen | Helaba Trust | |
19.01.05 | Givaudan Neutral | Sarasin Research | |
19.01.05 | Clariant Halten | Helaba Trust | |
19.01.05 | Nestlé In-Line | Goldman Sachs | |
19.01.05 | SGS SA Neutral | Sarasin Research | |
21.01.05 | Nestlé Kaufen | Helaba Trust | |
18.01.05 | Novartis Buy | AG Edwards | |
18.01.05 | Novartis Buy | Merrill Lynch | |
18.01.05 | Novartis Outperform | Bear Stearns | |
18.01.05 | Richemont Overweight | Lehman Brothers | |
18.01.05 | Nestlé Buy | Helvea | |
20.01.05 | Baloise Outperform | Goldman Sachs | |
18.01.05 | Novartis Buy | Merrill Lynch | |
18.01.05 | Sulzer Buy | Sarasin Research | |
20.01.05 | Zurich Insurance Outperform | Goldman Sachs | |
18.01.05 | Roche Buy | Merrill Lynch | |
24.01.05 | Baloise Reduce | Sal. Oppenheim | |
18.01.05 | Novartis Buy | Sarasin Research | |
20.01.05 | Sulzer Buy | Helvea | |
24.01.05 | Zurich Insurance Neutral | Sal. Oppenheim | |
24.01.05 | Swiss Life Neutral | Sal. Oppenheim | |
18.01.05 | Lonza Buy | Helvea | |
18.01.05 | Novartis Akkumulieren | Independent Research | |
18.01.05 | Swiss Prime Site Neutral | Helvea | |
18.01.05 | Swiss Prime Site Neutral | Helvea |